News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioCapital
Incyte Corporation to Present at the Leerink Swann and Company 2012 Global Healthcare Conference
February 3, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) announced today it will present at the Leerink Swann 2012 Global Healthcare Conference on Thursday, February 16, 2012 at 2:30 p.m. (ET) in New York.
Twitter
LinkedIn
Facebook
Email
Print
Events
Incyte
MORE ON THIS TOPIC
FDA
Biotech leaders call for streamlining of INDs as FDA’s TrialBlazer rolls out
August 3, 2026
·
9 min read
·
Jef Akst
Diabetes
Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independence
July 20, 2026
·
7 min read
·
Michael Gibney
Alzheimer’s disease
AAIC 2026: Anti-tau space begins to clarify as Biogen presents detailed data on antisense drug
July 15, 2026
·
6 min read
·
Heather McKenzie
Alzheimer’s disease
AAIC 2026: Tau-targeted Alzheimer’s treatments heat up while amyloid therapies persist
July 10, 2026
·
6 min read
·
Michael Gibney